Taylor Provides Insight Into Pirtobrutinib Resistance in CLL
Season 6, Episode 49, May 23, 2022, 08:14 PM
Dr Taylor discusses the significance of BTK inhibition in chronic lymphocytic leukemia, describes the key objectives of, and methods used, for the genomic analyses performed by his team, underscores the clinical significance of the data yielded from this research, and outlines where future efforts will focus.